PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up

International Journal of Radiation Oncology, Biology, Physics
Murat CalogluEric A Klein

Abstract

To determine clinical or dosimetric factors associated with a prostate-specific antigen (PSA) bounce, as well as an association between a PSA bounce and biochemical relapse-free survival (bRFS), in patients treated with iodine-125 brachytherapy. A variety of clinical and treatment factors were examined in 820 patients who had a minimum of 3 years of PSA follow-up with T1-T2cN0M0 prostate cancer. Four different PSA threshold values were used for defining a PSA bounce: a PSA rise of ≥ 0.2, ≥ 0.4, ≥ 0.6, and ≥ 0.8 ng/mL. A PSA bounce of ≥ 0.2, ≥ 0.4, ≥ 0.6, and ≥ 0.8 ng/mL was noted in 247 patients (30.1%), 161 (19.6%), 105 (12.8%), and 78 (9.5%), respectively. The median time to the first PSA rise was 17.4, 16.25, 16.23, and 15.71 months, respectively, vs. 34.35 months for a biochemical failure (p < 0.0001). A PSA rise of ≥ 0.2 ng/mL was the only definition for which there was a significant difference in bRFS between bounce and non-bounce patients. The 5-year bRFS rate of patients having a PSA bounce of ≥0.2 was 97.7% vs. 91% for those who did not have a PSA bounce (p = 0.0011). On univariate analysis for biochemical failure, age, risk group, and PSAs per year had a statistically significant correlation with PSA bounce of ≥ 0.2 n...Continue Reading

References

Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·S NagR Nath
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·S NagY Yu
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Richard G StockJamie A Cesaretti
Oct 11, 2005·International Journal of Radiation Oncology, Biology, Physics·Jay P CiezkiEric A Klein
Sep 18, 2007·International Journal of Radiation Oncology, Biology, Physics·Juanita CrookGina Lockwood
Jan 27, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sirpa H AaltomaaTapio Forsell

❮ Previous
Next ❯

Citations

Jun 8, 2012·Der Urologe. Ausg. A·T FranzJ-U Stolzenburg
Nov 28, 2012·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·R MazeronP Pommier
Dec 15, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Masashi MatsushimaMototsugu Oya
Aug 22, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Miren Gaztañaga, Juanita Crook
Sep 22, 2012·Asia-Pacific Journal of Clinical Oncology·Yun Hee LeeTae Kon Hwang
May 13, 2015·International Journal of Radiation Oncology, Biology, Physics·Jeffrey A KittelJay P Ciezki
Apr 19, 2015·Japanese Journal of Clinical Oncology·Hiromitsu KanzakiKatsuyoshi Hashine
Sep 7, 2014·International Journal of Clinical Oncology·Arash O NaghaviRichard B Wilder
Sep 23, 2014·Brachytherapy·Nelson N StoneRichard G Stock
Jul 13, 2016·British Journal of Cancer·Yoichiro YamamotoDavid Dingli
May 26, 2015·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Pedro GalegoLuís Campos Pinheiro
Dec 24, 2011·Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology·Yasuto YagiShiro Saito
Oct 29, 2019·The Journal of the American Osteopathic Association·Stephen AbelRussell Fuhrer
Mar 8, 2020·Cancers·Narisa Dewi Maulany DarwisTatsuya Ohno
May 18, 2016·Topics in Magnetic Resonance Imaging : TMRI·Francesca V MertanBaris Turkbey
Aug 9, 2020·Cancers·Narisa Dewi Maulany DarwisTatsuya Ohno
Aug 8, 2018·Journal of Radiation Research·Katsumaro KuboYasushi Nagata
Nov 15, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ting Martin MaAmar U Kishan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Juanita CrookGina Lockwood
International Journal of Radiation Oncology, Biology, Physics
Karel A HinnenMarco van Vulpen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Darren M MitchellJohn P Logue
© 2021 Meta ULC. All rights reserved